Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1813 to 1862 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
907\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba305p22.3 (breast carcinoma amplified sequence 4). [source:sptrembl;acc:q8ndy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11852.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10773.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10019\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8269.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8597.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03961\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
908\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11848.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10770.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7589.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7890.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03958\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
909\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5995.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6595.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10005\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8334.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8664.4\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03955\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
910\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8038.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.55\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6522.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7175.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09999\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
911\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8377.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8708.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03951\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 5 (c-myc binding protein mm-1) (myc modulator 1). [source:swissprot;acc:q99471]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5480.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09996\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
912\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8251.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8577.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5480.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09996\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
913\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadp-dependent malic enzyme, mitochondrial precursor (ec 1.1.1.40) (nadp-me) (malic enzyme 3). [source:swissprot;acc:q16798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8275.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8602.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03941\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 2 (wbp-2). [source:swissprot;acc:q969t9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6342.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09943\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
914\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6513.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7161\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09942\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7948.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8260.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03934\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
915\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6289.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6911.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09893\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7948.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8260.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03934\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
916\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase 1 (b5r.1). [source:refseq;acc:nm\_016243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6289.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6911.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09893\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7948.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8260.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03934\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
917\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 8 (26s proteasome regulatory subunit s14) (p31). [source:swissprot;acc:p48556]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8126.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8445.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03928\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-cytochrome b5 reductase (ec 1.6.2.2) (b5r). [source:swissprot;acc:p00387]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6289.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6911.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09893\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
918\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadp-dependent malic enzyme (ec 1.1.1.40) (nadp-me) (malic enzyme 1). [source:swissprot;acc:p48163]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8284.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8609.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03924\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
scratch; scratch 1. [source:refseq;acc:nm\_031309]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7281.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8001.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09888\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
919\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5396.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5929.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09878\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fer (ec 2.7.1.112) (p94-fer) (c-fer). [source:swissprot;acc:p16591]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7363.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7652.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03922\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
920\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj850e9.1 (novel c2h2 type zinc finger protein similar to drosophila scratch (scrt), slug and xenopus snail) (fragment). [source:sptrembl;acc:q9nq03]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7991.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0987\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fes/fps (ec 2.7.1.112) (c-fes). [source:swissprot;acc:p07332]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7363.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7652.73\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03921\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
921\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l29 (cell surface heparin binding protein hip). [source:swissprot;acc:p47914]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7363.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7652.55\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor if-2, mitochondrial precursor (if-2mt) (if-2(mt)). [source:swissprot;acc:p46199]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6324.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6948.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0987\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
922\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-tyrosine ligase. [source:refseq;acc:nm\_153712]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5511.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6054.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09862\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa-binding protein 2 (hcnp protein) (pp3898). [source:swissprot;acc:q9hcs7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7987.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8300.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03918\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
923\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 8 (eif3 p110) (eif3c). [source:swissprot;acc:q99613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4057.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4457.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09861\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-1 (ec 2.4.1.186). [source:swissprot;acc:p46976]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8186.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8506.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03915\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
924\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
opioid binding protein/cell adhesion molecule precursor (obcam) (opioid-binding cell adhesion molecule) (opcml). [source:swissprot;acc:q14982]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5406.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5939.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09857\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syndecan-3 (synd3). [source:swissprot;acc:o75056]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9050.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9404.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03912\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
925\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8398.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8726.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03909\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
[pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 1). [source:swissprot;acc:q15118]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5637.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6193.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09856\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
926\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8051.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8366.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03905\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
[pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 2). [source:swissprot;acc:q15119]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5637.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6193.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09856\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
927\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8005.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8318.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03902\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dipeptidylpeptidase 10; dipeptidyl peptidase iv-related protein 3. [source:refseq;acc:nm\_020868]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6194.22\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
928\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase assembly protein cox11, mitochondrial precursor. [source:swissprot;acc:q9y6n1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8287.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8610.75\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03902\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
929\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
citrate synthase, mitochondrial precursor (ec 2.3.3.1). [source:swissprot;acc:o75390]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8070.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8385.43\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
surfeit locus protein 1. [source:swissprot;acc:q15526]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
930\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dipeptidyl aminopeptidase-like protein 6 (dipeptidylpeptidase vi) (dipeptidylpeptidase 6) (dipeptidyl peptidase iv like protein) (dipeptidyl aminopeptidase-related protein) (dppx). [source:swissprot;acc:p42658]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5638.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6194.23\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor ts, mitochondrial precursor (ef-ts) (ef-tsmt). [source:swissprot;acc:p43897]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7928.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8237.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.039\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
931\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acidic leucine-rich nuclear phosphoprotein 32 family member c (tumorigenic protein pp32r1). [source:swissprot;acc:o43423]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7637.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7935.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03899\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seprase (ec 3.4.21.-) (fibroblast activation protein alpha) (integral membrane serine protease) (170-kda melanoma membrane-bound gelatinase). [source:swissprot;acc:q12884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6194.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/